Die Aktivierung und Funktion von Bactericidal / Permeability - Increasing Protein (BPI) bei entzündlichen Darmprozessen

Das Antimikrobielle Protein (AMP) Bactericidal / Permeability - Increasing Protein (BPI), welches in der Lage ist, Lipopolysaccharide (LPS) effektiv zu binden und damit zu neutralisieren, spielt bei Erkrankungen wie z.B cystischer Fibrose eine entscheidende Rolle. Allerdings ist bisher unklar, we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Stromiedel, Maria
Beteiligte: Schnare, Markus (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Sprache:Deutsch
Veröffentlicht: Philipps-Universität Marburg 2014
Medizin
Schlagworte:
BPI
Online Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

1. Moseley, T. A., D. R. Haudenschild, et al. (2003). "Interleukin-17 family and IL-17 receptors." Cytokine Growth Factor Rev 14(2): 155-74.


2. Podolsky, D. K. (2002). "Inflammatory bowel disease." N Engl J Med 347(6): 417-29.


3. Marks, D. J., M. W. Harbord, et al. (2006). "Defective acute inflammation in Crohn's disease: a clinical investigation." Lancet 367(9511): 668-78.


4. Malago, J. J., J. F. Koninkx, et al. (2002). "The heat shock response and cytoprotection of the intestinal epithelium." Cell Stress Chaperones 7(2): 191-9.


5. Akin, H., G. Tahan, et al. (2013). "Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease." J Crohns Colitis 5(1): 14-8.


6. Magalhaes, J. G., I. Tattoli, et al. (2007). "The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens." Semin Immunol 19(2): 106- 15.


7. Fukata, M., A. S. Vamadevan, et al. (2009). "Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders." Semin Immunol 21(4): 242-53.


8. Ayabe, T., T. Ashida, et al. (2004). "The role of Paneth cells and their antimicrobial peptides in innate host defense." Trends Microbiol 12(8): 394-8.


9. Donskey, C. J., A. M. Hujer, et al. (2003). "Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients." J Microbiol Methods 54(2): 249-56.


10. Abreu, M. T. (2010). "Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function." Nat Rev Immunol 10(2): 131-44.


11. Takeda, K. and S. Akira (2005). "Toll-like receptors in innate immunity." Int Immunol 17(1): 1-14.


12. Rahman, A., A. Fahlgren, et al. (2011). "Chronic colitis induces expression of beta- defensins in murine intestinal epithelial cells." Clin Exp Immunol 163(1): 123-30.


13. Cederlund, A., G. H. Gudmundsson, et al. (2011). "Antimicrobial peptides important in innate immunity." Febs J 278(20): 3942-51.


14. Scaldaferri, F. and C. Fiocchi (2007). "Inflammatory bowel disease: progress and current concepts of etiopathogenesis." J Dig Dis 8(4): 171-8.


15. Lees, C. W., J. C. Barrett, et al. (2011). "New IBD genetics: common pathways with other diseases." Gut 60(12): 1739-53.


16. Cappello, M., S. Keshav, et al. (1992). "Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation." Gut 33(9): 1214-9.


17. Ni, J., S. F. Chen, et al. (1996). "Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes." Gut 39(2): 234-41.


18. Wehkamp, J., K. Fellermann, et al. (2005). "Human defensins in Crohn's disease." Chem Immunol Allergy 86: 42-54.


19. Werts, C., S. Rubino, et al. (2011). "Nod-like receptors in intestinal homeostasis, inflammation, and cancer." J Leukoc Biol 90(3): 471-82.


20. Pone, E. J., Z. Xu, et al. (2012). "B cell TLRs and induction of immunoglobulin class- switch DNA recombination." Front Biosci 17: 2594-615.


21. Reynolds, J. M., G. J. Martinez, et al. (2012) "Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C." J Immunol 189(9): 4226-30.


22. Iimura, M., R. L. Gallo, et al. (2005). "Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens." J Immunol 174(8): 4901-7.


23. Liew, F. Y., D. Xu, et al. (2005). "Negative regulation of toll-like receptor-mediated immune responses." Nat Rev Immunol 5(6): 446-58.


24. Mowat, A. M. (2003). "Anatomical basis of tolerance and immunity to intestinal antigens." Nat Rev Immunol 3(4): 331-41.


25. Bouma, G. and W. Strober (2003). "The immunological and genetic basis of inflammatory bowel disease." Nat Rev Immunol 3(7): 521-33.


26. Kobayashi, K., N. Inohara, et al. (2002). "RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems." Nature 416(6877): 194-9.


27. Ogura, Y., D. K. Bonen, et al. (2001). "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease." Nature 411(6837): 603-6.


28. Solomon, M., Mallon, Donnelly,Hoper, Loughrey, Kirk, Gardiner (2010). "The dextran sulphate sodium (DSS) model of colitis: an overview." Comparativ Clinical Pathology 19(3): 235-239.


29. Brogden, K. A. (2005). "Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?" Nat Rev Microbiol 3(3): 238-50.


30. Dinarello, C. A. (1996). "Biologic basis for interleukin-1 in disease." Blood 87(6): 2095-147.


31. March, C. J., B. Mosley, et al. (1985). "Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs." Nature 315(6021): 641-7.


32. Tlaskalova-Hogenova, H., R. Stepankova, et al. (2004). "Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases." Immunol Lett 93(2-3): 97-108.


33. Papadakis, K. A. and S. R. Targan (1999). "Current theories on the causes of inflammatory bowel disease." Gastroenterol Clin North Am 28(2): 283-96.


34. Ito, H., K. Sekimura, et al. (2006). "[Cytoprotective effects of heat shock protein-70 in bronchial epithelium against neutrophil elastase-induced cell injury]." Arerugi 55(7): 820-6.


35. Ludwig, D., M. Stahl, et al. (1999). "Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases." Dig Dis Sci 44(7): 1440-7.


36. Becker, J. and E. A. Craig (1994). "Heat-shock proteins as molecular chaperones." Eur J Biochem 219(1-2): 11-23.


37. Kregel, K. C. (2002). "Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance." J Appl Physiol 92(5): 2177-86.


38. Feder, M. E. and G. E. Hofmann (1999). "Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology." Annu Rev Physiol 61: 243-82.


39. Kitajima, S., S. Takuma, et al. (2000). "Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights." Exp Anim 49(1): 9-15.


40. O'Neill, L. A. (2006). "How Toll-like receptors signal: what we know and what we don't know." Curr Opin Immunol 18(1): 3-9.


41. Wehkamp, J., K. Fellermann, et al. (2002). "Human beta-defensin 2 but not beta- defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease." Eur J Gastroenterol Hepatol 14(7): 745-52.


42. Ramirez-Carrozzi, V., A. Sambandam, et al. (2011). "IL-17C regulates the innate immune function of epithelial cells in an autocrine manner." Nat Immunol 12(12): 1159-66.


43. Macdonald, T. T. and G. Monteleone (2005). "Immunity, inflammation, and allergy in the gut." Science 307(5717): 1920-5.


44. Janeway, C. A. T., P.; Walport, M.; Shlomchik, M (2002). Immunolgie, Spektrum Akademischer Verlag Gustav Fischer (Heidelberg).


45. Musch, M. W., M. J. Ciancio, et al. (1996). "Induction of heat shock protein 70 protects intestinal epithelial IEC-18 cells from oxidant and thermal injury." Am J Physiol 270(2 Pt 1): C429-36.


46. Fiocchi, C. (1998). "Inflammatory bowel disease: etiology and pathogenesis." Gastroenterology 115(1): 182-205.


47. Medzhitov, R. and C. Janeway, Jr. (2000). "Innate immune recognition: mechanisms and pathways." Immunol Rev 173: 89-97.


48. Arai, Y., H. Takanashi, et al. (1998). "Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice." Cytokine 10(11): 890-


49. Casini-Raggi, V., L. Kam, et al. (1995). "Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation." J Immunol 154(5): 2434-40.


50. Reimund, J. M., C. Wittersheim, et al. (1996). "Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease." J Clin Immunol 16(3): 144-50.


51. Ouellette, A. J. and M. E. Selsted (1996). "Paneth cell defensins: endogenous peptide components of intestinal host defense." Faseb J 10(11): 1280-9.


52. Salzman, N. H., M. A. Underwood, et al. (2007). "Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa." Semin Immunol 19(2): 70-83.


53. Rensing, H. (2003). "[Endotoxins. Pathogenetic meaning of sepsis]." Anaesthesist 52


54. Weiss, J., P. Elsbach, et al. (1978). "Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes." J Biol Chem 253(8): 2664-72.


55. Hartmann, G., C. Bidlingmaier, et al. (2000). "Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice." J Pharmacol Exp Ther 292(1): 22-30.


56. Kawai, T. and S. Akira (2006). "TLR signaling." Cell Death Differ 13(5): 816-25.


57. Sansonetti, P. J. (2004). "War and peace at mucosal surfaces." Nat Rev Immunol 4(12): 953-64.


58. Baumgart, D. C. and A. U. Dignass (2002). "Intestinal barrier function." Curr Opin Clin Nutr Metab Care 5(6): 685-94.


59. Canny, G., E. Cario, et al. (2006). "Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein." Am J Physiol Gastrointest Liver Physiol 290(3): G557-67.


60. Salzman, N. H., et al. (2002) "Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria." Microbiology. 148:3651–3660.


61. Wehkamp, J., N. H. Salzman, et al. (2005). "Reduced Paneth cell alpha-defensins in ileal Crohn's disease." Proc Natl Acad Sci U S A 102(50): 18129-34.


62. O'Neil, D. A., E. M. Porter, et al. (1999). "Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium." J Immunol 163(12): 6718- 24.


63. Lennartsson, A., K. Pieters, et al. (2005). "A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow." J Leukoc Biol 77(3): 369-77.


64. Ayabe, T., D. P. Satchell, et al. (2000). "Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria." Nat Immunol 1(2): 113-8.


65. Artis, D. (2008). "Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut." Nat Rev Immunol 8(6): 411-20.


66. Canny, G., O. Levy, et al. (2002). "Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia." Proc Natl Acad Sci U S A 99(6): 3902-7.


67. Aichele, D., M. Schnare, et al. (2006). "Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients." Infect Immun 74(8): 4708-14.


68. Hornef, M. W., T. Frisan, et al. (2002). "Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells." J Exp Med 195(5): 559-70.


69. Stoffel, M. P., E. Csernok, et al. (1996). "Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders." Clin Exp Immunol 104(1): 54-9.


70. Yang, X. O., S. H. Chang, et al. (2008). "Regulation of inflammatory responses by IL- 17F." J Exp Med 205(5): 1063-75.


71. Schultz, H. and J. P. Weiss (2007). "The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease." Clin Chim Acta 384(1-2): 12-23.


72. Salzman, N. H., K. Hung, et al. (2010) "Enteric defensins are essential regulators of intestinal microbial ecology." Nat Immunol 11(1): 76-83.


73. Wells, J. M., O. Rossi, et al. (2011). "Epithelial crosstalk at the microbiota-mucosal interface." Proc Natl Acad Sci U S A 108 Suppl 1: 4607-14.


74. Benckert, J., N. Schmolka, et al. (2011). "The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific." J Clin Invest 121(5): 1946-55.


75. Khor, B., A. Gardet, et al. (2011). "Genetics and pathogenesis of inflammatory bowel disease." Nature 474(7351): 307-17.


76. Ho, S., C. Pothoulakis, et al. (2013). "Antimicrobial peptides and colitis." Curr Pharm Des 19(1): 40-7.


77. Kamdar, K., V. Nguyen, et al. (2013). "Toll-like receptor signaling and regulation of intestinal immunity." Virulence 4(3): 207-12.


78. Fearon, D. T. and R. M. Locksley (1996). "The instructive role of innate immunity in the acquired immune response." Science 272(5258): 50-3.


79. Okayasu, I., S. Hatakeyama, et al. (1990). "A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice." Gastroenterology 98(3): 694-702.


80. Chassaing, B. and A. Darfeuille-Michaud (2011). "The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases." Gastroenterology 140(6): 1720-28.


81. Elsbach, P. and J. Weiss (1998). "Role of the bactericidal/permeability-increasing protein in host defence." Curr Opin Immunol 10(1): 45-9.


82. Villegas, I., C. Alarcon de la Lastra, et al. (2003). "A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice." Int Immunopharmacol 3(13-14): 1731-41.


83. Isolauri, S. S., A Ouwehand (2004). "Probiotics." Best Practice & Research Clinical Gastroenterology 18(2): 299-313.


84. Henckaerts, L., C. Figueroa, et al. (2008). "The role of genetics in inflammatory bowel disease." Curr Drug Targets 9(5): 361-8.